论文部分内容阅读
急性胰腺炎是由于各种因素引起胰腺分泌多种消化酶,导致胰腺及其周围组织自身消化的一种急性疾病,占急腹症的第3～5位,且有逐年增加趋势.近年来,对急性重症胰腺炎的临床认识有明显提高,但死亡率仍较高,国外平均死亡率为9.5%,最高达20%.这与胰酶、毒物及血管活性物质的释放所产生的局部和全身作用密切相关.我院采用进口抑肽酶制剂特血乐治疗急性重症胰腺炎21用取得较好疗效.1 资料与方法1.1 一般资料 采用1996年1月～1977年3月住院急性重症胰腺炎患者41例,随机分为治疗组和对照组.其中治疗组21例,对照组20例,两组患者在性别、年龄、病史及入院时的白细胞、血尿淀粉酶、血糖、血钙等方面无明显差异,具有可比性.
Acute pancreatitis is due to various factors that cause the pancreas to secrete a variety of digestive enzymes, leading to the pancreas and its surrounding tissue to digest an acute disease, accounting for acute abdomen of the first 3 to 5, and increasing year by year.In recent years, Clinical awareness of acute severe pancreatitis has been significantly improved, but the mortality rate is still high, the average foreign mortality rate was 9.5%, up to 20% .This is pancreatic enzymes, toxins and vasoactive substances generated by the release of local and systemic The effect is closely related to our hospital imported aprotinin Teflon treatment of acute severe pancreatitis 21 with better efficacy.1 Materials and Methods 1.1 General Information The use of January 1996 ~ March 1977 hospitalized patients with severe acute pancreatitis 41 cases were randomly divided into treatment group and control group, including 21 cases in the treatment group and 20 cases in the control group.The two groups had no significant differences in the gender, age, medical history and leucocyte, hematuria, amylase, blood glucose and serum calcium Differences, comparable.